Related references
Note: Only part of the references are listed.The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone
Bradley D. Stein et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Perceptions of the State Policy Environment and Adoption of Medications in the Treatment of Substance Use Disorders
Hannah K. Knudsen et al.
PSYCHIATRIC SERVICES (2012)
Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation
Paul M. Roman et al.
ADDICTIVE BEHAVIORS (2011)
Adoption and Implementation of Medications in Addiction Treatment Programs
Hannah K. Knudsen et al.
JOURNAL OF ADDICTION MEDICINE (2011)
Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure
Hannah K. Knudsen et al.
EVALUATION AND PROGRAM PLANNING (2011)
Facilitating Factors and Barriers to the Use of Medications in Publicly Funded Addiction Treatment Organizations
Hannah K. Knudsen et al.
JOURNAL OF ADDICTION MEDICINE (2010)
Substance Abuse Treatment Organizations as Mediators of Social Policy: Slowing the Adoption of a Congressionally Approved Medication
Stanley S. Wallack et al.
JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH (2010)
Top Manager Effects on Buprenorphine Adoption in Outpatient Substance Abuse Treatment Programs
Peter D. Friedmann et al.
JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH (2010)
HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005
Harold A. Pollack et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2010)
Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science
Laura J. Damschroder et al.
IMPLEMENTATION SCIENCE (2009)
Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network
Hannah K. Knudsen et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2009)
Opiold treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoption
Lori J. Ducharme et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2009)
Dosage Patterns in Methadone Treatment: Results from a National Survey, 1988-2005
Harold A. Pollack et al.
HEALTH SERVICES RESEARCH (2008)
The meaning of translational research and why it matters
Steven H. Woolf
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
State policy influence on the early diffusion of buprenorphine in community treatment programs
Lori J. Ducharme et al.
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2008)
A Practical, Robust Implementation and Sustainability Model (PRISM) for Integrating Research Findings into Practice
Adrianne C. Feldstein et al.
JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY (2008)
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
R. P. Mattick et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Factors determining how early adopter physicians use buprenorphine in treatment
Sharon Reif et al.
JOURNAL OF ADDICTION MEDICINE (2007)
The adoption of innovations by provider organizations in health care
Colleen Beecken Rye et al.
MEDICAL CARE RESEARCH AND REVIEW (2007)
Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network
Lori J. Duchanne et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2007)
Characteristics of US substance abuse treatment facilities adopting buprenorphine in its initial stage of availability
Alison L. Koch et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectors
Hannah K. Knudsen et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2006)
Changes in methadone treatment practices - Results from a national panel study, 1988-2000
T D'Aunno et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
